Statin treatment depresses the fetal defence to acute hypoxia via increasing nitric oxide bioavailability

Journal of Physiology

Volumn 590, Issue 2, 2012, Pages 323-334

  Kane, Andrew D ^a   Herrera, Emilio A ^a   Hansell, Jeremy A ^a   Giussani, Dino A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; PRAVASTATIN;

ACUTE DISEASE; ACUTE HYPOXIA; ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; ARTICLE; BIOAVAILABILITY; CARDIOVASCULAR FUNCTION; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FEMORAL ARTERY FLOW; FETUS; FETUS CIRCULATION; FETUS HYPOXIA; GESTATION PERIOD; HYPOXIA; LACTIC ACIDOSIS; METABOLISM; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE; VASOCONSTRICTION;

ANIMALS; ANOXIA; ANTICHOLESTEREMIC AGENTS; BIOLOGICAL AVAILABILITY; BLOOD GAS ANALYSIS; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; ENDOCRINE SYSTEM; FEMALE; FETUS; MODELS, ANIMAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PRAVASTATIN; PREGNANCY; SHEEP; VASOMOTOR SYSTEM;

EID: 84855898255     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.217968     Document Type: Article

References (49)

1. Adam O & Laufs U (2008). Antioxidant effects of statins. Arch Toxicol 82, 885-892.
2. Ahmed A (2011). New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications. Thromb Res 127 (Suppl. 3), S72-S75.
3. Apatu RS & Barnes RJ (1991). Release of glucose from the liver of fetal and postnatal sheep by portal vein infusion of catecholamines or glucagon. J Physiol 436, 449-468.
4. Bartelds B, van Bel F, Teitel D & Rudolph A (1993). Carotid, not aortic, chemoreceptors mediate the fetal cardiovascular response to acute hypoxemia in lambs. Pediatr Res 34, 51-55.
5. Blum A & Shamburek R (2009). The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis 203, 325-330.
6. Boyle D, Hirst K, Zerbe G, Meschia G & Wilkening R (1990). Fetal hind limb oxygen consumption and blood flow during acute graded hypoxia. Pediatr Res 28, 94-100.
7. Buhaescu I & Izzedine H (2007). Mevalonate pathway: A review of clinical and therapeutical implications. Clin Biochem 40, 575-584.
8. Chen K & Keaney JF (2004). Reactive oxygen species-mediated signal transduction in the endothelium. Endothelium 11, 109-121.
9. Cohn HE, Sacks EJ, Heymann MA & Rudolph AM (1974). Cardiovascular responses to hypoxemia and acidemia in fetal lambs. Am J Obstet Gynecol 120, 817-824.
10. Dröge W (2002). Free radicals in the physiological control of cell function. Physiol Rev 82, 47-95.
11. Edison R & Muenke M (2004). Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Genet A 131, 287-298.
12. Gardner DS, Fletcher AJ, Fowden AL & Giussani DA (2001). A novel method for controlled and reversible long term compression of the umbilical cord in fetal sheep. J Physiol 535, 217-229.
13. Gardner DS, Fowden AL & Giussani DA (2002). Adverse intrauterine conditions diminish the fetal defense against acute hypoxia by increasing nitric oxide activity. Circulation 106, 2278-2283.
14. Gardner DS & Giussani DA (2003). Enhanced umbilical blood flow during acute hypoxemia after chronic umbilical cord compression: a role for nitric oxide. Circulation 108, 331-335.
15. Gelosa P, Cimino M, Pignieri A, Tremoli E, Guerrini U & Sironi L (2007). The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. Vasc Health Risk Manag 3, 567-577.
16. Giussani DA, Gardner DS, Cox DT & Fletcher AJ (2001). Purinergic contribution to circulatory, metabolic, and adrenergic responses to acute hypoxemia in fetal sheep. Am J Physiol Regul Integr Comp Physiol 280, R678-R685.
17. Giussani DA, Spencer JA, Moore PJ, Bennet L & Hanson MA (1993). Afferent and efferent components of the cardiovascular reflex responses to acute hypoxia in term fetal sheep. J Physiol 461, 431-449.
18. Gomes ME, Tack CJ, Verheugt FW, Smits P & Lenders JWM (2010). Sympathoinhibition by atorvastatin in hypertensive patients. Circ J 74, 2622-2626.
19. Green LR, Bennet L & Hanson MA (1996). The role of nitric oxide synthesis in cardiovascular responses to acute hypoxia in the late gestation sheep fetus. J Physiol 497, 271-277.
20. Green LR, McGarrigle HHG, Bennet L & Hanson MA (1998). The role of endothelin-A receptors in cardiovascular responses to acute hypoxaemia in the late gestation sheep fetus. J Physiol 509, 297-304.
21. Heffner LJ (2004). Advanced maternal age - how old is too old? N Engl J Med 351, 1927-1929.
22. Hooper SB (1995). Fetal metabolic responses to hypoxia. Reprod Fertil Dev 7, 527-538.
23. Jones CT (1977). The development of some metabolic responses to hypoxia in the foetal sheep. J Physiol 265, 743-762.
24. Jones CT & Ritchie JW (1983). The effects of adrenergic blockade on fetal response to hypoxia. J Dev Physiol 5, 211-222.
25. Jones CT & Robinson RO (1975). Plasma catecholamines in foetal and adult sheep. J Physiol 248, 15-33.
26. Kaesemeyer WH, Caldwell RB, Huang J & Caldwell RW (1999). Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol 33, 234-241.
27. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC & Walsh K (2000). The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6, 1004-1010.
28. Laufs U, La Fata V, Plutzky J & Liao JK (1998). Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97, 1129-1135.
29. 2+-activated potassium currents. J Neurophysiol 103, 3027-3033.
30. Low JA (2004). Reflections on the occurrence and significance of antepartum fetal asphyxia. Best Pract Res Clin Obstet Gynaecol 18, 375-382.
31. McCrabb G & Harding R (1996). Role of nitric oxide in the regulation of cerebral blood flow in the ovine foetus. Clin Exp Pharmacol Physiol 23, 855-860.
32. Maki-Petaja K & Wilkinson I (2009). Anti-inflammatory drugs and statins for arterial stiffness reduction. Curr Pharm Des 15, 290-303.
33. Mondo CK, Yang W-S, Zhang N & Huang T-G (2006). Anti-oxidant effects of atorvastatin in dexamethasone-induced hypertension in the rat. Clin Exp Pharmacol Physiol 33, 1029-1034.
34. Morrison S, Gardner DS, Fletcher AJ, Bloomfield MR & Giussani DA (2003). Enhanced nitric oxide activity offsets peripheral vasoconstriction during acute hypoxaemia via chemoreflex and adrenomedullary actions in the sheep fetus. J Physiol 547, 283-291.
35. National-Center-for-Health-Statistics (2010). Health, United States, 2010: With Special Feature on Death and Dying. Hyattsville, Maryland
36. Pliquett RU, Cornish KG & Zucker IH (2003). Statin therapy restores sympathovagal balance in experimental heart failure. J Appl Physiol 95, 700-704.
37. Poore KR, Boullin JP, Cleal JK, Newman JP, Noakes DE, Hanson MA & Green LR (2010). Sex- and age-specific effects of nutrition in early gestation and early postnatal life on hypothalamo-pituitary-adrenal axis and sympathoadrenal function in adult sheep. J Physiol 588, 2219-2237.
38. Reller MD, Burson MA, Lohr JL, Morton MJ & Thornburg KL (1995). Nitric oxide is an important determinant of coronary flow at rest and during hypoxemic stress in fetal lambs. Am J Physiol Heart Circ Physiol 269, H2074-H2081.
39. Rudolph A (1985). Distribution and regulation of blood flow in the fetal and neonatal lamb. Circ Res 57, 811-821.
40. StAmP (2011). The StAmP trial: A proof of principle, double-blind, randomised placebo-controlled, multi centre trial of pravastatin to ameliorate early onset pre-eclampsia.
41. Steinberg D (2008). The statins in preventive cardiology. N Engl J Med 359, 1426-1427.
42. Taguchi N, Rubin ET, Hosokawa A, Choi J, Ying AY, Moretti ME, Koren G & Ito S (2008). Prenatal exposure to HMG-CoA reductase inhibitors: Effects on fetal and neonatal outcomes. Reprod Toxicol 26, 175-177.
43. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K & Imaizumi T (1997). Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 95, 76-82.
44. Thakor A & Giussani D (2009). Nitric oxide reduces vagal baroreflex sensitivity in the late gestation fetus. Pediatr Res 65, 269-273.
45. Thakor AS & Giussani DA (2005). Role of nitric oxide in mediating in vivo vascular responses to calcitonin gene-related peptide in essential and peripheral circulations in the fetus. Circulation 112, 2510-2516.
46. Thakor AS, Herrera EA, Serón-Ferré M & Giussani DA (2010a). Melatonin and vitamin C increase umbilical blood flow via nitric oxide-dependent mechanisms. J Pineal Res 49, 399-406.
47. Thakor AS, Richter HG, Kane AD, Dunster C, Kelly FJ, Poston L & Giussani DA (2010b). Redox modulation of the fetal cardiovascular defence to hypoxaemia. J Physiol 588, 4235-4247.
48. Torrens C, Kelsall CJ, Hopkins LA, Anthony FW, Curzen NP & Hanson MA (2009). Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner. Hypertension 53, 661-667.
49. Weir EK & Archer SL (2010). The role of redox changes in oxygen sensing. Respir Physiol Neurobiol 174, 182-191.